LabRoots is excited to bring academia and industry, research experts, virologists, microbiologists, healthcare professionals, and leading biomedical scientists under one roof at our 6th Annual Microbiology Virtual Week, held on September 8-10, 2020!
Microbiology Virtual Week 2020 will offer a 3-day content-rich program offering invited lectures, thought-provoking discussions and posters to explore global developments for the prevention, diagnosis, and treatment of Infectious Diseases, discoveries in Microbiology & Immunology research to improve human, animal, and plant health, including virology, pathogenesis, genomics and epidemiology, microbial communities and biofilms, and research to find improved vaccines, diagnostics, and antiviral drugs for Influenza.
This year's event will include the following topics and tracks:
Our virtual conference allows you to participate in a global setting with no travel or cost to you. The event will remain open 6 months from the date of the live event. The webinars will be available for unlimited on-demand viewing. This virtual conference also offers increased reach for the global microbiology community with a high degree of interaction through live-streaming video and chat sessions.
Like the 2019 conference, this event will be produced on our robust platform, allowing you to watch, learn and connect seamlessly across all desktop or mobile devices. Equipped with gamification and point system, you can now move around the entire event, earning points for a chance to win one of LabRoots' most popular T-shirts.
Call for Posters — Virtual poster sessions offer the opportunity to present data to a global audience via a PDF poster and video summary and discuss results with interested colleagues through email. Plan now to have your poster included in the 2020 Microbiology Virtual Week. Submit your free abstract here.
Continuing Education - LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this event, you can earn 1 Continuing Education credit per presentation for a maximum of 50 credits.
Use #LRmicro to follow the conversation!
Dr. Alvarez is an Assistant Professor, in the division of Infectious Diseases at the Ichan School of Medicine at Mount Sinai, where his work focuses on the antibody-mediated mechanisms that correlate with HIV-1 suppression in HIV-1 controller patients. Dr. Alvarez has over 20 years experience conducting translational research in the infectious disease space. He is also the co-founder and CEO of Ichor Biologics, a pre-clinical biotechnology start-up that is dedicated to accelerating therapeutics in the infectious disease space. Dr. Alvarez received his BSc. in Molecular Biology & Biochemistry from Boston University, an MSc. in the Immunology of Infectious Disease from the London School of Hygiene and Tropical Medicine and a PhD from King's College London in Molecular Virology.
Dr. Bickhart is a Research Microbiologist/Bioinformatician at the US Department of Agriculture’s Dairy Forage Research Center, where his work focuses on genome assembly of livestock species and their associated microbiomes. He has 10 years of experience in the field of Bioinformatics and Genome Informatics, and applies new technologies and algorithms to solve problems in agricultural production systems. Dr. Bickhart has been a contributor or team leader for many of the recently released reference genomes for agricultural species. The goal of this research is to improve the sustainability of agricultural systems by enabling predictive modeling of animal production with the inclusion of animal and microbial genomic information.
Jesse Bloom is a professor at the Fred Hutch Cancer Research Center and an Investigator of the Howard Hughes Medical Institute. The Bloom lab uses a mix of experiment and computation to study the evolution of viruses. Jesse received his PhD in Caltech where he worked with Frances Arnold, and then performed postdoctoral work with David Baltimore also at Caltech. Jesse started his own research group at the Fred Hutch in 2011.
Dr. Candice M. Brown is an assistant professor in the Department of Neuroscience and Rockefeller Neuroscience Institute at the West Virginia University School of Medicine. She received her PhD in Genetics and Genomics from Duke University and completed postdoctoral training at the University of California, Davis and the University of Washington. She joined the Center for Basic and Translational Stroke Research at West Virginia University in October 2014. The goal of her research is to understand how sex differences modify interactions between the brain and the immune system, with an emphasis on the brain’s vascular system. Recent studies have focused on longitudinal changes in the gut microbiome and the enteric nervous system in animal models of sepsis, ischemic stroke, and Alzheimer’s disease.
Dr. Costantini completed her doctorate degree in Biomedical Research at Albert Einstein College of Medicine in New York. Dr. Costantini’s research focus integrates her background in cellular and molecular biology and virology with high-resolution microscopy approaches. At North Carolina Central University, Dr. Costantini’s research lab studies the replication and lifecycle of human herpesvirus, Kaposi’s Sarcoma Herpesvirus. More specifically, the viral DNA replication machinery and the factors that may influence viral replication.
Dr. James Crowe is Director of the Vanderbilt Vaccine Center and the Ann Scott Carell Professor of Pediatrics, Pathology, Microbiology and Immunology at Vanderbilt. His laboratory studies the human immune response to infection for a wide variety of major human pathogens, including many emerging infections. His research group uses a very broad array of techniques including molecular and cellular biology, single-cell biology and synthetic genomics, state-of-the-art imaging and flow cytometry, bioinformatics, and bioengineering approaches to attack scientific problems at the forefront of immunity research. The group has been recognized widely as a leader in antibody sciences, for instance as the Best Academic Research Team, 11th Annual Vaccine Industry Excellence Awards, World Vaccine Congress, recipient of the 2019 Merck Future Insight Prize for Pandemic Preparedness, and large-scale research grants and contracts from NIH and DoD, including the DARPA Pandemic Prevention Program (P3).
Santiago Elena is CSIC professor and chairman of the Institute for Integrative Systems Biology (I2SysBio), where he is the head of the Evolutionary and Systems Virology group. In addition, he is an external professor at the Santa Fe Institute (NM, USA). He graduated in Biochemistry from the University of Valencia and did a PhD thesis on Evolutionary Genetics of RNA viruses. He did a postdoc in the Center for Microbial Ecology at Michigan State University and a sabbatical stay in the Section of Ecology, Evolution and Behavior at UC San Diego. His work has always focused on the study of the mechanisms by which RNA viruses adapt to their hosts and how this adaptation results in the manipulation of cellular resources for their own benefit. For this work, he combines experimental evolution, advanced molecular biology, molecular epidemiology, and mathematical modeling. Among other merits, he is an elected member of the European Organization for Molecular Biology (EMBO), the Chinese Academy of Agronomic Sciences (CAAS), and the American Academy of Arts and Sciences (AAA&S).
Michael Goodin employs live-cell imaging to investigate the cellular biology of plant-adapted rhabdoviruses, and other RNA viruses. He has made seminal contributions particularly regarding the mechanism of nuclear transport of viral proteins, their ability to modify nuclear membranes, and identification of host factors implicated in cell-to-cell movement. He is presently focused on the identification and characterization of emerging plant viruses in Brazil, including the mite-transmitted coffee ringspot virus. Like zoonotic viruses, plant viruses, particularly those with arthropod vectors, share the ability to jump species barriers, which results in their “emergence” into new host populations. He conducted his postdoctoral research at the University of California-Berkeley, graduate research at The Pennsylvania State University, and received his undergraduate degree from Brock University. He communicates how fundamental principles of science are relevant to everyday life via original essays posted on his blog at greenorangecafe.org.
Gang Fang is an Associate Professor in the Genomics Department at Icahn School of Medicine at Mount Sinai. He is also part of the Icahn Institute for Genomics and Multiscale Biology. The Fang lab pioneered the fast growing field of bacterial epigenomics, and developed the foundational methods that enabled the effective use of Single Molecule Real-Time (SMRT) sequencing technology for direct detection of DNA modifications. Since 2012, his lab has characterized the epigenomes of hundreds of bacterial species, identifying novel epigenetic mechanisms regulating bacterial gene expression, virulence, biofilm formation and sporulation etc. Recently, his lab pioneered the use of DNA methylation for high resolution microbiome analysis. Dr. Fang received his PhD degree in University of Minnesota in 2012, his MS degree in University at Buffalo, 2007, and his BS degree in Fudan University, 2005. Dr. Fang received multiple awards including: Joint Mayo Clinic - IBM Research Traineeship (2007), Best Network Model Award, Sage Congress (2010), Walter Barnes Lang Fellowship (2011), Best Dissertation Award at University of Minnesota (2012), Kavli Frontiers in Science Fellow (2013), Nash Family Research Scholar, Friedman Brain Institute (2016), Hirschl Research Award, Irma T. Hirschl Trust (2018).
Dr. Juliet Morrison is an Assistant Professor at the University of California Riverside. Her research combines immunological and virological methods with computational analysis to address questions at the host-pathogen interface. A major interest of the Morrison Lab is understanding how emerging and re-emerging viruses antagonize innate immune pathways to promote their replication. They also use virus-encoded interferon antagonists as tools to define previously unknown aspects of interferon signaling regulation. Another interest of Professor Morrison is using tissue deconvolution algorithms and immunological tools to study the dynamics of lung immune cell populations during influenza virus infections, and spleen and liver immune cell populations during dengue virus infections. Her goal is to translate these findings into host-targeted influenza and flavivirus therapeutics.
Dr. O'Hara has developed cutting edge next-gen sequencing-based technology for hospitals and spent five years commercializing this technology. She has led unprecedented, large-scale metagenomics work characterizing the microbiome of ambulances across the US, hospital environments, the urine microbiome, and SARS-CoV-2 samples. She completed a postdoc in health tech business at Cornell Tech (2018), a postdoc at Fordham University in Bioinformatics (2015), a PhD in Ecology and Evolutionary Biology at Stony Brook University (2014), and a BA at NYU (2005). Dr. O'Hara has published peer-reviewed articles in the fields of metagenomics, genomics, evolutionary biology and ecology in top ranked journals such as Molecular Ecology, Microbiome, and Evolution. Her work has been featured in GenomeWeb, Popular Science, the Huffington Post, and WIRED.
Dominic O’Neil has over 13 years of experience in the biotechnology industry. Before joining QIAGEN, he gained molecular biology expertise at several companies, including three years at the Whitehead/MIT Center for Genome Research in Cambridge, MA, where he participated in the completion of the initial draft of the human genome. Dominic joined Digene (which later became part of QIAGEN) in 2004 to work on new technology research and development, focusing in particular on sample preparation and diagnostic applications. In 2011, he joined the QIAGEN R&D group in Hilden as a Senior Scientist to work on solutions for next-generation sequencing. He is now the Director R&D for Microbiome Product Development.
Peter Palese is a Professor of Microbiology and the Chair of the Department of Microbiology at the Icahn School of Medicine at Mount Sinai. His research is in the area of RNA-containing viruses with a special emphasis on influenza viruses. Specifically, he established the first genetic maps for influenza A, B, and C viruses, identified the function of several viral genes, and defined the mechanism of neuraminidase inhibitors (which are now FDA-approved antivirals). He was also a pioneer in the field of reverse genetics for negative strand RNA viruses, which allows the introduction of site-specific mutations into the genomes of these viruses. This technique is crucial for the study of the structure/function relationships of viral genes, for investigation of viral pathogenicity and for development and manufacture of novel vaccines. An improvement of this technique has been effectively used by him and his colleagues to reconstruct and study the pathogenicity of the highly virulent, but extinct, 1918 pandemic influenza virus. Work in collaboration with Dr. Adolfo Garcia-Sastre has revealed that most negative strand RNA viruses possess proteins with interferon antagonist activity, enabling them to counteract the antiviral response of the infected host. In recent years most of the efforts by Dr. Palese and by his collaborators at Mount Sinai, Dr. Adolfo Garcia-Sastre and Dr. Florian Krammer, have been directed at developing a Universal Influenza Virus Vaccine. Since the beginning of the year there has been a shift in directions as work on COVID-19 has become central to the efforts by Dr. Palese. Dr. Palese is a Member of the National Academy of Sciences, a Member of the National Academy of Medicine, a Fellow of the American Academy of Arts and Sciences, and a Fellow of the National Academy of Inventors
Dr. Rasmussen is a virologist studying host responses to infection by combining classical virology with modern systems biology approaches. Her research objectives are to identify host response signatures predictive of infection severity or disease outcome and host pathways to target drug development or repurposing. She is particularly interested in viruses that are highly pathogenic, newly emergent or likely to emerge because of climate change, land development, or ecological disruption. Dr. Rasmussen has employed Collaborative Cross (CC) mouse models, which provide an expanded range of disease presentations, to study viral disease characteristics. At the University of Washington, she developed a CC mouse model of Ebola virus disease, utilizing the diversity of CC mouse disease phenotypes to study genetic and transcriptomic factors underlying disease severity in humans. She is currently evaluating CC mouse models towards investigation of sex-specific host responses to viral infection, as well as to investigate disease presentation in other viruses that pose a major threat to global public health, such as dengue virus, influenza virus, and SARS-CoV-2. Ultimately, these host response profiles can be used for translational or biodefense applications, such as diagnosing infection, predicting disease severity, informing vaccine design, and developing or repurposing host-targeted drugs to impair virus replication or reverse pathology.
I am a Ph.D. candidate in Bioinformatics and Computational Biology at the University of Minnesota. My advisor, computer scientist Rui Kuang, and I are interested in discovering how high-throughput sequencing technologies can be used to understand the complex genetics of the KIR (killer-cell immunoglobulin-like receptors).
Dr. Melissa Smith is an Assistant Professor of Biochemistry and Molecular Genetics at the University of Louisville. She joined the faculty there in July of this year, after spending the prior four years managing the Genomics Technology Core team at the Icahn School of Medicine at Mount Sinai. Dr. Smith's personal research focuses on utilizing cutting edge genomics technologies to investigate host-pathogen interactions. Specifically, she has been using single molecule, real-time (SMRT) sequencing methods to define mechanisms of viral immune evasion and profile host immune repertoires for more than six years. Ongoing work in her laboratory utilizes the long, phased reads provided by SMRT sequencing to reconstruct and profile the incredibly complex immune loci in the human genome (HLA, Ig, TCR) as well as viral surveillance and evolution, including SARS-CoV2 and HIV.
Dr. Tyler Starr is an HHMI Damon Runyon Postdoctoral Fellow in Jesse Bloom’s lab at the Fred Hutchinson Cancer Research Center in Seattle, Washington. He researches the molecular evolution of viral and immune genes, combining computational evolutionary analyses with high-throughput experimental assays to characterize the effects of amino-acid mutations on protein function. These experiments highlight biochemical constraints on protein function, inform the design of vaccines and antibody therapeutics, and illuminate the evolutionary forces that shape key viral and immune proteins.
Imre Varju is a Fulbright Scholar in medical science and a Health Communication Specialist with nearly 10 years of experience working with Neutrophil Extracellular Traps, with a special focus on their contribution to immunothrombosis. He obtained his MD and PhD at Semmelweis University, Hungary, completed postdoctoral trainings at the Hungarian Academy of Sciences, the National Institute for Biological Standards for Control, UK and at Harvard Medical School, and obtained his MPH at Columbia University. On top, he has been working as a Health Education Strategist at FCB Health New York.
Detlef Weigel, a German-American scientist, is currently Executive Director of the Max Planck Institute for Developmental Biology. He is a member of the US National Academy of Sciences, the German National Academy of Sciences Leopoldina and the Royal Society, and recipient of several scientific awards, most recently the Novozymes Prize of the Novo Nordisk Foundation. The first major finding from his lab was that an Arabidopsis gene could dramatically accelerate flowering of trees; this established a proof of concept for Arabidopsis genetics as a platform for biotechnological discoveries. His group later discovered the first plant microRNA mutant and identified the factor that we now know to be the long sought-after mobile flower-inducing signal. Detlef was also one of the first to exploit natural genetic variation for understanding how the environment affects plant development. In recent years, this work has come to incorporate questions at the interface of evolution and ecology: How can wild plants adapt to climate change, and how do they manage to keep their pathogens at bay? In this research, he draws on the fruits of a collaborative effort initiated over a decade ago to sequence the genomes of over 1,000 natural A. thaliana strains (The 1001 Genomes Project). Detlef has an extensive record of service to the scientific community, having served on a series of editorial and advisory boards. He is a forceful advocate of open access publishing and founding Deputy Editor of eLife. He is a co-founder of three biotech startups.
POSTER SUBMISSION GUIDELINES
Virtual poster sessions offer the opportunity to present data to a global audience via a PDF poster and video summary, and discuss results with interested colleagues through email. Posters should be submitted as a PowerPoint file. Presentations should incorporate illustrative materials such as tables, graphs, photographs, and large-print text. This content is not peer-reviewed. Submission is free.
SUBMIT YOUR ABSTRACT
Enter the following information to this Submission Form:
All submitted abstracts will be reviewed and decisions regarding acceptance will be made as abstracts are received. You will be notified within one week of receipt about acceptance. Further details and registration materials will be provided at that time. You do not have to be present in order to have a poster displayed. Only those abstracts approved by LabRoots may display posters at this event.
If accepted, you will also have the opportunity to record a 3-5 minute summary video for each poster. LabRoots will work with each individual to create these videos. Video links and email contact information will be included on each poster displayed.
Questions? Email Posters@LabRoots.com
DiaSorin Molecular LLC manufactures and distributes molecular diagnostic products worldwide helping laboratories to streamline workflow and improve patient management. Our Simplexa® molecular kits include HSV-1 & 2, Flu A/B & RSV, Bordetella, VZV, Group A Strep, Group B ...See more See less
For 60 years The Baker Company has been at the forefront of engineering, testing and production of reliable laboratory contamination control equipment. Recognized as the industry pioneer, The Baker Company maintains an unparalleled passion for helping our customers advance ...See more See less
Millipore Sigma is a leading science and technology company in healthcare, life science and performance materials. Around 50,000 employees work to further develop technologies that improve and enhance life - from biopharmaceutical therapies to treat cancer or multiple sclerosis ...See more See less
Luminex's mission is to empower labs to obtain reliable, timely, and actionable answers, ultimately advancing health. We offer a wide range of solutions applicable in diverse markets including clinical diagnostics, pharmaceutical drug discovery, biomedical research, genomic and ...See more See less
The American Biological Safety Association (ABSA) was founded in 1984 to promote biosafety as a scientific discipline and serve the growing needs of biosafety professionals throughout the world. The Association's goals are to provide a professional association that represents the ...See more See less
Manuscriptedit specializes in providing services in Scientific & English editing, proofreading, medical writing, academic writing, formatting and publication support. Within a short span of time, the company has grown rapidly to be counted among the world's leading service ...See more See less
Thermo Fisher Scientific is the world leader in serving science. Our mission is to enable our customers to make the world healthier, cleaner, and safer. We serve life science researchers from academic institutions and pharmaceutical industry, providing an unmatched combination of ...See more See less
QIAGEN N.V., a Netherlands holding company, is the leading global provider of Sample & Assay Technologies that are used to transform biological materials into valuable molecular information. Sample technologies are used to isolate and process DNA, RNA and proteins from biological ...See more See less
At MicroGEM, we have re-invented DNA and RNA extraction. We replace traditional extraction methods with a simple, single-tube approach. Our thermophilic and mesophilic enzymes are derived from extremophiles living in the world's harshest environments. Our specially-formulated ...See more See less
The speakers below have been approved for Continuing Education Credits. To redeem your credits, locate the presentation you watched and click on the CE buttons for further direction. For more general information regarding continuing education, the processes to receive credits, and the accreditation bodies, Click here
Meredith Ashby is the Director of Market Strategy for Microbial Genomics, Cancer and Immunology at Pacific Biosciences. She completed her Ph.D. at Caltech mapping the gene regulatory networks that direct sea urchin development just as the sea urchin genome was being sequenced ...See more See less
Dr Ivan Brukner entered into genomic era back in 1989 (ex-Yugoslavia), trying to describe and solve repeating sequence "branching motif problem" in building whole genome sequence. Next 5-10 years, his research was targeting sequence-dependent DNA structural problems, where ...See more See less
Dr. Ehrlich is Professor of Microbiology and Immunology, and Otolaryngology-Head and Neck Surgery at Drexel University College of Medicine (DUCoM) in Philadelphia, PA, USA. He also directs: the Center for Genomic Sciences (CGS); the Center for Advanced Microbial Processing ...See more See less
Jennifer M. Fettweis, Ph.D. is the founder and director of the Research Alliance for Microbiome Science (RAMS) Registry and assistant professor in the Departments of Microbiology and Immunology and Obstetrics and Gynecology at Virginia Commonwealth University. From 2009-2019, she ...See more See less
Matt entered the research field over 20 years ago as a lab animal technician at the TSI/Mason contract research facility. He has worked at both contract facilities such as TSI and OREAD Biosafety as well in industry at Pharmacia, Pfizer, and Sanofi-Aventis. During that period he ...See more See less
Dr. García-Sastre is Professor in the Departments of Microbiology and Medicine and in the Tisch Cancer Center at Icahn School of Medicine Mount Sinai (ISMMS) in New York,. He is also Director of the Global Health and Emerging Pathogens Institute at ISMMS, and Principal ...See more See less
Dr. Emily Hollister is a microbial ecologist and serves as the Vice President for Information Technology & Analytics at Diversigen, Inc. Prior to joining Diversigen, Dr. Hollister served as an Assistant Professor in the Department of Pathology & Immunology at Baylor College of ...See more See less
Jonas Korlach was appointed Chief Scientific Officer of Pacific Biosciences in July 2012. He was previously a Scientific Fellow, supporting commercial development of the PacBio RS II system and performing research aimed at developing new applications for SMRT technologies. He ...See more See less
Stephen S. Morse, Ph.D., is Professor of Epidemiology at the Columbia University Mailman School of Public Health, where he also serves as Director of the Infectious Disease Epidemiology certificate and as chair of the Columbia University Institutional Biosafety Committee (IBC) ...See more See less
Dr. Roossinck received a PhD in 1986 from the University of Colorado School of Medicine in Microbiology and Immunology, studying Hepatitis B virus, on an National Institutes of Health fellowship. Following a postdoctoral fellowship at Cornell University, where she began studying ...See more See less
Professor Emeritus John G. Thomas, PhD, is recognized as an "International Educator and Global Microbiologist " (www.globalbugs.com) having lectured in more than 43 countries while a clinical microbiologist in pathology (Professor), dentistry (Clinical Professor) and ...See more See less
|Operating System||Internet Explorer||Firefox||Chrome||Safari|
|Windows 7||IE8+||FF10+||Chrome15+||Windows 8||IE10||FF10+||Chrome15+|
|Mac OS X||FF10+||Chrome15+||Safari5.1+|
- For viewing Webinars:
- For viewing Virtual Events